Wells Fargo Sticks to Their Buy Rating for Dexcom (DXCM)
DexCom Analyst Ratings
DexCom Initiated at Outperform by RBC, Price Target Set at $165 on View for Revenue Upside Amid Rapidly Expanding Market
Wells Fargo Remains a Buy on Dexcom (DXCM)
Analysts Are Bullish on These Healthcare Stocks: Wave Life Sciences (WVE), Dexcom (DXCM)
Piper Sandler Sticks to Its Buy Rating for Dexcom (DXCM)
Dexcom's Stelo Launch Fuels Buy Rating on Expansive Market Opportunity
Analysts Conflicted on These Healthcare Names: AMN Healthcare Services (AMN) and Dexcom (DXCM)
Analysts' Opinions Are Mixed on These Healthcare Stocks: Dexcom (DXCM), Orthofix (OFIX) and Medtronic (MDT)
Analysts Conflicted on These Healthcare Names: Dexcom (DXCM), Gilead Sciences (GILD) and Sanofi (OtherSNYNF)
Analysts Offer Insights on Healthcare Companies: Senseonics Holdings (SENS), Azitra Inc (AZTR) and Dexcom (DXCM)
Analysts Offer Insights on Healthcare Companies: Molina Healthcare (MOH), Dexcom (DXCM) and Tenaya Therapeutics (TNYA)
Analysts Offer Insights on Healthcare Companies: Zoetis (ZTS), Dexcom (DXCM) and Gilead Sciences (GILD)
Canaccord Genuity Adjusts DexCom Price Target to $144 From $137, Maintains Buy Rating
Dexcom's Strong Performance and Expansion Strategies Merit a Buy Rating
Analysts Offer Insights on Healthcare Companies: Dexcom (DXCM), Vaxcyte (PCVX) and Vertex Pharmaceuticals (VRTX)
Analysts' Opinions Are Mixed on These Healthcare Stocks: Apellis Pharmaceuticals (APLS), Dexcom (DXCM) and Nanosonics Limited (OtherNNCSF)
DexCom Analyst Ratings
Dexcom's Strong Financial Outlook and Promising Product Pipeline Merit a Buy Rating
Analysts Are Bullish on These Healthcare Stocks: Dexcom (DXCM), Evolent Health (EVH)
No Data